Androgen and prolactin (Prl) levels in systemic sclerosis (SSc): Relationship to disease severity

Annals of the New York Academy of Sciences

Volumn 1069, Issue , 2006, Pages 257-262

  Mirone, Luisa ^a   Barini, Angela ^a   Barini, Antonella ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b School of Medicine   (Italy)

Author keywords

Dehydroepiandrosterone sulfate; Prolactin; Systemic sclerosis; Testosterone

Indexed keywords

ANDROGEN; PRASTERONE SULFATE; PROLACTIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; CHEMOLUMINESCENCE; CHRONIC DISEASE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; ELECTROCHEMILUMINESCENCE IMMUNOASSAY; FEMALE; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HUMAN; IMMUNOSTIMULATION; MALE; PROLACTIN BLOOD LEVEL; SCORING SYSTEM; SYSTEMIC SCLEROSIS; TISSUE INJURY;

EID: 33745588536     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1351.023     Document Type: Conference Paper

References (14)

1. SMITH E.A. & E.C. LEROY. 1997. Connective tissue diseases - systemic sclerosis: etiology and pathogenesis. In J. Klippel, P.A. Dieppe, Eds.: Rheumatology, second edition. London: Mosby Yearbook Europe.
2. WHITE B. 1996. Immunopathogenesis of systemic sclerosis. Rheum. Dis. Clin. North. Am. 22: 695-708.
3. VISELLI, S.M., E.M. STANEK, P. MUKHERJEE, et al. 1991. Prolactin-induced mitogenesis of lymphocytes from ovariectomized rats. Endocrinology 129: 983-990.
4. CLEVENGER, C.V, S.W. ALTMANN & M.B. PRYTOWSKY. 1991. Requirement of nuclear prolactin for interleukin-2-stimulated proliferation of T cells. Science 53: 77-79.
5. SUZUKI T., N. SUZUKI, R.A. DAYNES & E.G. ENGELEMAN. 1991. Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells. Clin. Immunol. Imunopathol. 61: 202-211.
6. OLSEN, N.J. & W.J. KOVACS. 2001. Effects of androgens on T and B lymphocyte development. Immunol. Res. 23: 281-288.
7. NOWLIN, N.S., J.E. BRICK, D.J. WEAVER, et al. 1986. Impotence in scleroderma. Ann. Int. Med. 104: 794-798.
8. LUSCINSKAS, F.W. & M.A. Jr GIMBRONE. 1996. Endothelial-dependent mechanisms in chronic inflammatory leukocyte recruitment. Annu. Rev. Med. 47: 413-421.
9. VAN VOLLENHOVEN, R.F. 1995. Adhesion molecules, sex steroids and the pathogenesis of vasculitis syndromes. Curr. Opin. Rheumatol. 7: 4-10.
10. TANRIVERDI F., L.F.G. SILVEIRA, G.S. MACCOLL & P.M.G. BOULOUX. 2003. The hypothalamic-pituitary-gonadal axis. J. Endocrinol. 176: 293-304.
11. LA MONTAGNA G., A. BARUFFO, G. BUONO, & G. VALENTINI. 2001. Dehydroepiandrosterone sulphate serum levels in systemic sclerosis. Clin. Exp. Rheumatol. 19: 21-26.
12. STRAUB, R.H., M. ZEUNER, G. LOCK, et al. 1997. High prolactin and low dehydroepiandrosterone sulphate serum levels in patients with severe systemic sclerosis. Br. J. Rheumatol. 36: 426-432.
13. JIMENEZ, S.A., E. HITRAYA & J. VARGA. 1996. Pathogenesis of scleroderma: collagen. Rheum. Dis. Clin. North Am. 22: 647-674.
14. HILTY C., P. BRUHLMANN, H. SPROTT, et al. 2000. Altered diurnal rhythm of prolactin in systemic sclerosis. J. Rheumatol. 27: 2160-2165.